...
首页> 外文期刊>Journal of Human Reproductive Sciences >Anesthetic management for oocyte retrieval: An exploratory analysis comparing outcome in in vitro fertilization cycles with and without pre-implantation genetic diagnosis
【24h】

Anesthetic management for oocyte retrieval: An exploratory analysis comparing outcome in in vitro fertilization cycles with and without pre-implantation genetic diagnosis

机译:卵母细胞取回的麻醉管理:一项探索性分析,比较有无植入前遗传学诊断的体外受精周期的结果

获取原文
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE:To date, there has been no comparison of outcomes in women undergoing anesthesia for in vitro fertilization (IVF) oocyte retrieval for the purpose of pre-implantation genetic diagnosis (PGD) because of their or their partner's genetic disease relative to the outcome in women requiring IVF because of fertility issues.MATERIALS AND METHODS:A prospective observational study, wherein all demographic and anesthetic management data were collected from IVF and PGD units' records for a 6-month period. Descriptive analyses and parametric tests were employed.RESULTS:There were 307 cases IVF and 76 cases PGD: most (97.4% and 99.7%, respectively) received general anesthesia with propofol and fentanyl ± dipyrone (90.5% and 93.3%, respectively) with no adverse effects. The only statistically significant difference between IVF and PGD groups that was potentially clinically significant was post-procedure recovery time (23.0 ± 20.4 vs. 29.4 ± 35.8 min, respectively; P < 0.0001), but is explainable as greater caution by Anesthesiologists for higher-risk PGD cases having autosomal dominant diseases that may impact anesthesia management (myotonic dystrophy, neurofibromatosis, Marfan's); two of these cases also recovered in the general post-anesthesia care unit, as a precaution for early diagnosis and treatment of potential post-procedural complication.CONCLUSIONS:Results of this first-ever survey of anesthesia for PGD compared with IVF cases imply that propofol-and-fentanyl-based anesthesia is safe and can be recommended, bearing in mind that with patients who have autosomal dominant diseases impacting anesthetic management it is prudent to be more cautious post-recovery.
机译:目的:迄今为止,由于其女性或伴侣的遗传性疾病相对于结局的结果,目前尚无比较将麻醉用于体外受精(IVF)卵母细胞以进行植入前遗传诊断(PGD)的妇女的结局。材料和方法:一项前瞻性观察性研究,其中从IVF和PGD单位的记录中收集了6个月的所有人口统计和麻醉管理数据。结果:IVF 307例,PGD 76例:大多数(分别为97.4%和99.7%)接受了异丙酚和芬太尼±双嘧啶的全身麻醉,分别为90.5%和93.3%。不利影响。 IVF组和PGD组之间唯一可能在临床上具有显着统计学意义的差异是术后恢复时间(分别为23.0±20.4和29.4±35.8分钟; P <0.0001),但麻醉医师应谨慎对待较高的预后。具有常染色体显性疾病的PGD风险病例,可能影响麻醉管理(强直性营养不良,神经纤维瘤病,马凡氏病);这些病例中有2例也已在全身麻醉后监护病房中康复,作为早期诊断和治疗潜在的术后并发症的预防措施。考虑到常染色体显性疾病影响麻醉管理的患者,谨慎行恢复后的谨慎是明智的,并且建议使用基于芬太尼的麻醉。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号